Ads
related to: meningococcal pneumonia isolation precautions recommendations- Prescribing Information
Visit official HCP website and find
full Prescribing Information.
- Antimicrobial Activity
A list of susceptible pathogens in
clinical infections and/or in vitro
- Clinical Safety
Review clinical safety data and
Important Safety Information here.
- Request A Rep / Sample
Fill in a form and request
a sample or a representative.
- Prescribing Information
Search results
Results From The WOW.Com Content Network
Transmission-based precautions are infection-control precautions in health care, in addition to the so-called "standard precautions". They are the latest routine infection prevention and control practices applied for patients who are known or suspected to be infected or colonized with infectious agents, including certain epidemiologically important pathogens, which require additional control ...
Meningococcal meningitis is a form of bacterial meningitis. Meningitis is a disease caused by inflammation and irritation of the meninges, the membranes surrounding the brain and spinal cord. In meningococcal meningitis this is caused by the bacteria invading the cerebrospinal fluid and circulating through the central nervous system. Sub ...
A poster outlining precautions for airborne transmission in healthcare settings. It is intended to be posted outside rooms of patients with an infection that can spread through airborne transmission. [1] Video explainer on reducing airborne pathogen transmission indoors
Page:2007 Guidelines for Isolation Precautions.pdf/9 Metadata This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.
Short-term antibiotic prophylaxis is another method of prevention, particularly of meningococcal meningitis. In cases of meningococcal meningitis, preventative treatment in close contacts with antibiotics (e.g. rifampicin, ciprofloxacin or ceftriaxone) can reduce their risk of contracting the condition, but does not protect against future ...
A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine licensed for people older than 55. MPSV4 may be used in people 2–55 years old if the MCV4 vaccines are not available or contraindicated. Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first ...
Ads
related to: meningococcal pneumonia isolation precautions recommendations